Company profile: Ionpath
1.1 - Company Overview
Company description
- Provider of ion beam–based multiplexed tissue imaging and spatial proteomics solutions, including the MIBIscope system with instrumentation, validated reagents, and visualization software; MIBI technology imaging 40+ protein markers per scan; MIBIplus single-cell analysis detecting 50+ phenotypes; Spatial Proteomic Services for segmentation, classification, and spatial analysis; and conjugated antibodies.
Products and services
- Multiplexed Ion Beam Imaging (MIBI): High-definition technology that analyzes tissue microenvironments by imaging 40+ protein markers per single scan using ion beam-based spatial proteomics
- MIBIscope System: System for highly multiplexed tissue imaging and analysis, including robust instrumentation, validated reagents, and visualization software
- Spatial Proteomic Services: Quantitative MIBI-enabled services for phenotype mapping and insight generation, offering cell segmentation, classification, and spatial analysis of tissue biopsies
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Ionpath
Joinn Biologics
HQ: United States
Website
- Description: Provider of contract development and manufacturing services for biologics and advanced therapies, from early development to IND to commercial stage, including cell line development (proprietary and CHO-K1), master cell banking, upstream/downstream process and cGMP manufacturing, protein purification, and analytics to assess quality and impurities.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Joinn Biologics company profile →
SEPS Pharma
HQ: Belgium
Website
- Description: Provider of drug product development services, encompassing preformulation and formulation development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SEPS Pharma company profile →
Caliper Life Sciences
HQ: United States
Website
- Description: Provider of integrated systems consisting of instruments, software and reagents, laboratory automation tools, and assay and discovery services for pharmaceutical and biotechnology companies, and government and other not-for-profit research institutions worldwide.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Caliper Life Sciences company profile →
Guava Technologies
HQ: United States
Website
- Description: Provider of biotechnology and medical devices, including unique flow cytometry and benchtop cell analysis systems. Offers HIV/AIDS monitoring, viacount cell counting and viability assays, antibody quantification, apoptosis assay suite, cell cycle, cytotoxicity, and cell proliferation assays.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Guava Technologies company profile →
Emulate
HQ: United States
Website
- Description: Provider of advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Emulate company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Ionpath
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Ionpath
2.2 - Growth funds investing in similar companies to Ionpath
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Ionpath
4.2 - Public trading comparable groups for Ionpath
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →